FEATURED

Fact Sheet: Pesticides and Cancer

Epidemiologic data, primarily from case-control studies, suggest that different types of pesticides are associated with specific types of cancer among children and adults.

Rare Cancer: An Underserved Area

As more rare cancers are identified, the need for rethinking approaches to research will become greater.

RCC: Overexpression of CKAP4, Poor Prognosis

Overexpressed CKAP4 was significantly associated with tumor, nodal, and metastasis stages, as well as Fuhrman grades.

Education Level: PSA Screening, Survival

Socioeconomic status, including education and income level, appears to be tied to prostate-specific antigen test results and prostate cancer treatment and survival, but the exact nature of these associations is not yet clear.

Do ACAs Affect Response and Survival?

Although cytogenetic abnormalities that arise during the course of CML are prevalent in later stages of the disease and are associated with a poorer prognosis, as many as 10% to 12% of patients exhibit ACAs at diagnosis.

Inflammatory Microenvironments, Therapy Effectiveness

Targeting tumor and extracellular LPA could help deny tumors their inflammatory habitat and improve the efficacy of radiotherapy, chemotherapy, and possibly immunotherapies.

Immunotherapy Re-challenge in Metastatic Melanoma

It is not always clear whether patients who discontinue anti-PD-1 and -CTLA-4 therapy should re-initiate treatment after adverse events are resolved.

Beta-blockers, Stress-induced Treatment Resistance

The results of this study support previous findings that psychological distress is associated with an increased risk of mortality among patients with lung cancer.

Fact Sheet: Red Meat and Cancer

Epidemiologic evidence suggests that high consumption of red meat, particularly beef, is associated with an increased risk of several types of cancer.

Nano-pulse Stimulation Shows Preclinical Promise

NPS with electrodes is under investigation as a potential new ablative — and possibly immunotherapeutic — cancer treatment modality.

Ask the Experts: Treating Hepatocellular Carcinoma

Cancer Therapy Advisor interviewed 3 experts about how to best treat sarcoma.

Paul Bunn, MD: ESMO 2017 Congress

Paul Bunn, Jr, MD, distinguished professor in the division of medical oncology and James Dudley chair of lung cancer research at the University of Colorado, Denver, discusses important lung cancer research presented at the ESMO 2017 Congress.

Ask The Experts: Treating Sarcoma

Cancer Therapy Advisor interviewed 3 experts about how to best treat sarcoma.

Explore a combination therapy

Read about a triplet-based therapy for multiple myeloma patients who have received at least one prior treatment.

For the treatment of metastatic non-small

Biomarker testing for epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations is important when considering a first-line therapy

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Explore a combination therapy

Read about a triplet-based therapy for multiple myeloma patients who have received at least one prior treatment.

Latest Features

Rare Cancer: An Underserved Area of Oncology

Rare Cancer: An Underserved Area of Oncology

As more rare cancers are identified, the need for rethinking approaches to research will become greater.

Overexpression of CKAP4 Linked With Poor Prognosis in Renal Cell Carcinoma

Overexpression of CKAP4 Linked With Poor Prognosis in Renal Cell Carcinoma

Overexpressed CKAP4 was significantly associated with tumor, nodal, and metastasis stages, as well as Fuhrman grades.

Does Education Level Predict PSA Screening and Prostate Cancer Survival?

Does Education Level Predict PSA Screening and Prostate Cancer Survival?

Socioeconomic status, including education and income level, appears to be tied to prostate-specific antigen test results and prostate cancer treatment and survival, but the exact nature of these associations is not yet clear.

Do Additional Chromosomal Abnormalities Noted at CML Diagnosis Affect Response and Survival?

Do Additional Chromosomal Abnormalities Noted at CML Diagnosis Affect Response and Survival?

Although cytogenetic abnormalities that arise during the course of CML are prevalent in later stages of the disease and are associated with a poorer prognosis, as many as 10% to 12% of patients exhibit ACAs at diagnosis.

Can Targeting Inflammatory Microenvironments Improve Cancer Therapy Effectiveness?

Can Targeting Inflammatory Microenvironments Improve Cancer Therapy Effectiveness?

Targeting tumor and extracellular LPA could help deny tumors their inflammatory habitat and improve the efficacy of radiotherapy, chemotherapy, and possibly immunotherapies.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters